Many modern drugs are based on antibodies. These proteins very specifically identify a certain structure on the surface of ...

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an ...

Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...

Researchers at UZH have developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse ...

Antibody mAb 3A6 takes advantage of this little ... who solved the X-ray structure; Zunlong Ke, who performed the cryoelectron tomography; Lisa Evans DeWald, Sara McArdle, Ariadna Grinyó, Edgar ...

Notably, the team successfully designed antibodies targeting ALK7, a protein without an experimentally resolved structure, as well as antibodies targeting a novel epitope of FZD7 discriminating ...

One of the most promising antibodies identified, VX22, targets a previously unknown weak spot in the virus's structure. Unlike typical antibodies that attack only one or two strains, VX22 ...

DUBLIN--(BUSINESS WIRE)--The "PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies ... clinical profile and molecular structure of drug candidates and business deals from an industry perspective ...